Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung Therapy Combined AI 360 platform for respiratory wellness

In a first, the AI-app based platform ARTIHealth™, developed by Mateon Therapeutics will enable patients to monitor progress of their respiratory function over the time by enabling them to upload daily cough and speech recording and receiving feedback on the health of their lungs.